Bayer reveals data behind asundexian's stroke win Bayer's oral Factor XIa inhibitor asundexian can reduce the risk of a secondary ischaemic stroke by 26%, according to the OCEANIC-STROKE trial

#Bayer #asundexian #stroke #oralFactorXIainhibitor #FactorXIainhibitor #ischaemicstroke #OCEANICSTROKEstudy #antiplatelettherapy #InternationalStrokeConference #phase3trial #secondarystrokeprevention #anticlottingtherapies #OCEANICSTROKE #acutecoronarysyndromes #preventionofstroke
zurl.co/Mhc1J

Hopstem maps course to bring stem cell stroke therapy to US China's Hopstem has been cleared to move straight to a phase 2 trial in the US for its stem cell-based therapy to aid recovery after a stroke.

China's #HopstemBiotech has been cleared to start #clinicaltrials of a #stemcell-based therapy for #ischaemicstroke in the US, following negotiations with the FDA.

pharmaphorum.com/news/hopstem...

Health Insight: Stroke can happen to anyone - an expert explains how to spot the signs and act fast - Sight Magazine In an article first published on The Conversation, SIOBHAN MCLERNON looks at what a stroke is and how to recognise its signs...

Health Insight: Stroke can happen to anyone – an expert explains how to spot the signs and act fast. @sightmagazine.bsky.social #HealthInsight #stroke #BEFAST #ischaemicstroke #haemorrhagicstroke #TIA

sightmagazine.com.au/health-insig...

#MedSky🧪#publichealth #publichealth A cohort of 4069 patients who had an acute #ischaemicstroke from 26 hospitals was examined. 5 systolic BP trajectories were identified by using latent mixture modelling: trajectory category 5 (190–170 mm Hg), trajectory category 4 (180–140 mm Hg),

A range of conditions #GuillainBarrésyndrome, #cognitivedeficit , #insomnia , #anxietydisorder, #encephalitis, #ischaemicstroke,
#mooddisorder exhibited a pronounced increase in long-term risk.